The Advanced Therapies Congress has hosted Europe’s largest commercially focused ATMP event in the UK for the past 18 years, and now we’re bringing our show to Philadelphia, Pennsylvania’s cell and gene hub! We will be bringing together decision makers from key biotech and pharma companies, putting forward a good ratio of buyers and sellers in our audience.
This year we are delighted to be able to provide
FREE
passes for all Spark Therapeutics employees, offering full access to the conference!
DAY 1 - 12th November
11:30am - 12:30pm
Klaudia Kuranda
Head of Immunology
Roundtable 3
Mitigation Strategies for Immune Response to AAV Gene Therapy
1:50pm - 2:30pm
Sean Armour
SVP, Head of Discovery
Panel discussion in Gene Therapy track
Right time, right place: challenges in targeting and new modalities for delivery
DAY 2 - 13th November
2:30pm - 2:50pm
Snehal Naik
Head of Regulatory Policy
Panel discussion in Regulation and Policy track
First-in-human trials – overcoming regulatory hurdles faced by academics and early-stage companies
2:50pm - 3:10pm
Klaudia Kuranda
Head of Immunology
Presentation in Gene Therapy track
Immune responses to AAV Gene Therapies
3:40pm - 4:00pm
Quan Jin
Capsid Engineering Lead
Presentation in Gene Therapy track
The Challenging Journey to Change the Tropism of AAV Vectors
Offer applies to Spark Therapeutics employees only. All guest pass applications subject to Terrapinn approval